Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs JUBILANT PHARMOVA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS JUBILANT PHARMOVA IPCA LABS/
JUBILANT PHARMOVA
 
P/E (TTM) x 51.7 -2,647.7 - View Chart
P/BV x 5.4 1.7 320.3% View Chart
Dividend Yield % 0.3 0.9 36.7%  

Financials

 IPCA LABS   JUBILANT PHARMOVA
EQUITY SHARE DATA
    IPCA LABS
Mar-23
JUBILANT PHARMOVA
Mar-23
IPCA LABS/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs1,062496 214.3%   
Low Rs768269 285.7%   
Sales per share (Unadj.) Rs243.0394.4 61.6%  
Earnings per share (Unadj.) Rs19.4-4.1 -476.0%  
Cash flow per share (Unadj.) Rs29.730.7 96.7%  
Dividends per share (Unadj.) Rs4.005.00 80.0%  
Avg Dividend yield %0.41.3 33.4%  
Book value per share (Unadj.) Rs230.3338.6 68.0%  
Shares outstanding (eoy) m253.70159.28 159.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.81.0 388.6%   
Avg P/E ratio x47.2-93.8 -50.3%  
P/CF ratio (eoy) x30.812.4 247.5%  
Price / Book Value ratio x4.01.1 352.0%  
Dividend payout %20.6-122.7 -16.8%   
Avg Mkt Cap Rs m232,12060,873 381.3%   
No. of employees `000NANA-   
Total wages/salary Rs m12,87621,660 59.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,64262,817 98.1%  
Other income Rs m1,518383 396.0%   
Total revenues Rs m63,16063,201 99.9%   
Gross profit Rs m9,0337,317 123.5%  
Depreciation Rs m2,6165,540 47.2%   
Interest Rs m4821,882 25.6%   
Profit before tax Rs m7,453278 2,682.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,534927 273.4%   
Profit after tax Rs m4,919-649 -758.2%  
Gross profit margin %14.711.6 125.8%  
Effective tax rate %34.0333.5 10.2%   
Net profit margin %8.0-1.0 -772.7%  
BALANCE SHEET DATA
Current assets Rs m51,89337,624 137.9%   
Current liabilities Rs m18,05817,724 101.9%   
Net working cap to sales %54.931.7 173.3%  
Current ratio x2.92.1 135.4%  
Inventory Days Days5125 208.9%  
Debtors Days Days656 10.5%  
Net fixed assets Rs m34,33671,668 47.9%   
Share capital Rs m254159 159.5%   
"Free" reserves Rs m58,16753,772 108.2%   
Net worth Rs m58,42053,931 108.3%   
Long term debt Rs m6,51831,104 21.0%   
Total assets Rs m86,229109,292 78.9%  
Interest coverage x16.51.1 1,434.8%   
Debt to equity ratio x0.10.6 19.3%  
Sales to assets ratio x0.70.6 124.4%   
Return on assets %6.31.1 555.2%  
Return on equity %8.4-1.2 -699.9%  
Return on capital %12.22.5 481.1%  
Exports to sales %42.90-   
Imports to sales %13.34.1 325.0%   
Exports (fob) Rs m26,434NA-   
Imports (cif) Rs m8,1782,564 318.9%   
Fx inflow Rs m26,4347,100 372.3%   
Fx outflow Rs m8,1782,564 318.9%   
Net fx Rs m18,2574,536 402.5%   
CASH FLOW
From Operations Rs m8,0586,607 122.0%  
From Investments Rs m-7,250-5,444 133.2%  
From Financial Activity Rs m5,072-1,567 -323.7%  
Net Cashflow Rs m5,881301 1,953.7%  

Share Holding

Indian Promoters % 46.3 47.4 97.7%  
Foreign collaborators % 0.0 3.3 -  
Indian inst/Mut Fund % 44.8 23.2 193.2%  
FIIs % 10.3 20.3 50.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 49.3 108.9%  
Shareholders   82,809 86,588 95.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IPCA Labs vs Jubilant Pharmova

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs Jubilant Pharmova Share Price Performance

Period IPCA Labs Jubilant Pharmova S&P BSE HEALTHCARE
1-Day 3.35% -0.54% 1.18%
1-Month 4.27% 2.20% -0.75%
1-Year 56.49% 109.28% 61.82%
3-Year CAGR 9.46% -6.79% 18.16%
5-Year CAGR 20.88% -2.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the Jubilant Pharmova share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of Jubilant Pharmova the stake stands at 50.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of Jubilant Pharmova.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

Jubilant Pharmova paid Rs 5.0, and its dividend payout ratio stood at -122.7%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of Jubilant Pharmova.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.